“Molecular Mechanisms of FDA-Approved Drugs for the Treatment of Alzheimer’s Disease: A Comprehensive Review”. Molecular Medicine Communications 5, no. 1 (June 30, 2025): 17–28. Accessed April 3, 2026. https://rootspress.org/journals/MMC/article/view/1795.